SE9601527D0 - Transdermally alministered acetylcysteine as mucolytic agent - Google Patents

Transdermally alministered acetylcysteine as mucolytic agent

Info

Publication number
SE9601527D0
SE9601527D0 SE9601527A SE9601527A SE9601527D0 SE 9601527 D0 SE9601527 D0 SE 9601527D0 SE 9601527 A SE9601527 A SE 9601527A SE 9601527 A SE9601527 A SE 9601527A SE 9601527 D0 SE9601527 D0 SE 9601527D0
Authority
SE
Sweden
Prior art keywords
alministered
acetylcysteine
transdermally
optionally
mucolytic
Prior art date
Application number
SE9601527A
Other languages
English (en)
Inventor
Ulla Hoeck
Bo Krellgaard
Christina Nathansen
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE9601527A priority Critical patent/SE9601527D0/sv
Publication of SE9601527D0 publication Critical patent/SE9601527D0/sv
Priority to PCT/SE1997/000483 priority patent/WO1997039741A1/en
Priority to US09/171,673 priority patent/US6620428B1/en
Priority to AU21871/97A priority patent/AU2187197A/en
Priority to ZA9703016A priority patent/ZA973016B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9601527A 1996-04-23 1996-04-23 Transdermally alministered acetylcysteine as mucolytic agent SE9601527D0 (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE9601527A SE9601527D0 (sv) 1996-04-23 1996-04-23 Transdermally alministered acetylcysteine as mucolytic agent
PCT/SE1997/000483 WO1997039741A1 (en) 1996-04-23 1997-03-21 Transdermally administered acetylcysteine as mucolytic agent
US09/171,673 US6620428B1 (en) 1996-04-23 1997-03-21 Transdermally administered acetylcysteine as mucolytic agent
AU21871/97A AU2187197A (en) 1996-04-23 1997-03-21 Transdermally administered acetylcysteine as mucolytic agent
ZA9703016A ZA973016B (en) 1996-04-23 1997-04-09 Transdermally administered acetylcysteine as mucolytic agent.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9601527A SE9601527D0 (sv) 1996-04-23 1996-04-23 Transdermally alministered acetylcysteine as mucolytic agent

Publications (1)

Publication Number Publication Date
SE9601527D0 true SE9601527D0 (sv) 1996-04-23

Family

ID=20402294

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9601527A SE9601527D0 (sv) 1996-04-23 1996-04-23 Transdermally alministered acetylcysteine as mucolytic agent

Country Status (5)

Country Link
US (1) US6620428B1 (sv)
AU (1) AU2187197A (sv)
SE (1) SE9601527D0 (sv)
WO (1) WO1997039741A1 (sv)
ZA (1) ZA973016B (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1317736B1 (it) * 2000-01-26 2003-07-15 A C R Applied Coating Res S A Cerotto per la somministrazione locale e transdermica di principiattivi dotati di gruppi anionici ed elettronattrattori.
AU2000250055A1 (en) * 2000-04-13 2001-10-30 Lectec Corporation Therapeutic patch containing a liquid or gel organic compound as a carrier
EP1343492B1 (en) * 2000-11-22 2006-02-01 Rxkinetix, Inc. Treatment of mucositis
DE10230558B4 (de) * 2002-07-05 2007-08-02 Lts Lohmann Therapie-Systeme Ag Medizinisches Set zur Verabreichung in einer Kombinationstherapie
US20060020035A1 (en) * 2004-03-11 2006-01-26 Oregon Health & Science University Bone marrow protection with N-acetyl-L-cysteine
US20050234024A1 (en) * 2004-04-14 2005-10-20 Clarke David E Materials and methods for the treatment of ulcerative colitis
EP1888025B1 (en) * 2005-06-08 2020-08-12 Basf Corporation Medicament carrier composition and method of forming a film therefrom
AU2006320538B2 (en) * 2005-11-30 2013-07-04 Endo Pharmaceuticals Inc. Treatment of xerostomia with a sulfur-containing antioxidant
US20080317673A1 (en) 2007-06-20 2008-12-25 Fatema Salem Al-Thallab Method for diagnosing and treating bronchial asthma
CA3170545A1 (en) * 2020-02-11 2021-08-19 Babak Ghalili Cannabinoid and menthol transdermal delivery systems and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0481294T4 (da) * 1990-10-19 2001-06-18 Spirig Ag Fast, hurtigt-opløseligt lægemiddelpræparat indeholdende N-acetylcystein
AU7176094A (en) 1993-06-18 1995-01-17 Arcturus Pharmaceutical Corporation Method for treating hyperkeratosis and diseases mediated by proteases
JPH10502355A (ja) 1994-06-23 1998-03-03 ザ、プロクター、エンド、ギャンブル、カンパニー Ｎ−アセチル−ｌ−システインを含んだ局所組成物

Also Published As

Publication number Publication date
WO1997039741A1 (en) 1997-10-30
AU2187197A (en) 1997-11-12
ZA973016B (en) 1997-11-04
US6620428B1 (en) 2003-09-16

Similar Documents

Publication Publication Date Title
CA2341063A1 (en) Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder
EP0164998A3 (en) Compositions and methods of enhancing transdermal and transmembrane penetration of topical and systemic agents
DK0814796T3 (da) Anvendelse af et R-NSAID i en protektiv sammensætning til behandling af kolorektal cancer
ATE238778T1 (de) Transdermales therapeutisches system zur abgabe von hormonen
CA2251966A1 (en) Transdermally administered dextromethorphan as antitussive agent
DE69715049T2 (de) Tranilast enthaltendes externum und verfahren zu dessen herstellung
NO20034684D0 (no) Innretning for administrering av midler gjennom stratum corcum
GEP20043354B (en) Therapeutic Formulation for Administering Tolterodine with Controlled Release
TW200502017A (en) Active agent delivery device having composite members
ATE69720T1 (de) Transdermales system fuer timolol.
ID27503A (id) Tts yang mengandung antioksidan
ES2013129A6 (es) Procedimiento de obtencion de una composicion farmaceutica a base de n-metil-n- (1-fenil -2- propil) -2- propinilamina.
ATE290856T1 (de) Hydroxide freisetzende verbindungen zum verbessern der hautdurchlässigkeit
SE9601527D0 (sv) Transdermally alministered acetylcysteine as mucolytic agent
DK261490D0 (da) New pharmaceutical compound
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
MY111718A (en) Deuterated active substances in transdermal application
AU2003292006A1 (en) 3,5,3'-triiodothyronine sulfate as thyromimetic agent and pharmaceutical formulations thereof
ATE81775T1 (de) Pharmazeutische zusammensetzungen.
IE810489L (en) Composition for topical application
GEP20043231B (en) Resorcinol Composition
ES2143389A1 (es) Solucion cutanea para deposito directo destinado a la eliminacion de parasitos en bovinos y ovinos.
DK0705085T3 (da) Molykylært transdermalt transportsystem
CO5031290A1 (es) Formulacion lo
EP1011672A4 (en) CONNECTIONS WITH ANALGETIC EFFECT AND COMPILATIONS THAT CONTAIN THEM